Streptococcus pyogenes Infections - Pipeline Review, H2 2018

Publisher Name :
Date: 17-Jul-2018
No. of pages: 36
Inquire Before Buying

Streptococcus pyogenes Infections - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes Infections - Pipeline Review, H2 2018, provides an overview of the Streptococcus pyogenes Infections (Infectious Disease) pipeline landscape.

Streptococcus pyogenes infections are caused by Streptococcus pyogenes, a spherical, Gram-positive bacterium. Symptoms include significant pain, swelling, and redness of infected area, fever, dizziness, difficulty breathing, dangerously low blood pressure, and a weak, rapid pulse. Treatment includes antibiotics and healthy lifestyle.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Streptococcus pyogenes Infections - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Streptococcus pyogenes Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in IND/CTA Filed, Preclinical and Discovery stages are 1, 4 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.

Streptococcus pyogenes Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Streptococcus pyogenes Infections (Infectious Disease).

- The pipeline guide reviews pipeline therapeutics for Streptococcus pyogenes Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Streptococcus pyogenes Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Streptococcus pyogenes Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Streptococcus pyogenes Infections (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Streptococcus pyogenes Infections (Infectious Disease).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Streptococcus pyogenes Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Streptococcus pyogenes Infections - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Streptococcus pyogenes Infections - Overview
Streptococcus pyogenes Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Streptococcus pyogenes Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Streptococcus pyogenes Infections - Companies Involved in Therapeutics Development
Absynth Biologics Ltd
AstraZeneca Plc
Cadila Pharmaceuticals Ltd
Crestone Inc
Helix BioMedix Inc
Wellstat Vaccines LLC
Streptococcus pyogenes Infections - Drug Profiles
(mupirocin calcium + neomycin sulfate + HT-61) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AZ-6142 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HB-1345 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit PolC for Gram-Positive Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus [serotype A] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
streptococcus pyogenes (30-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Streptococcus pyogenes Infections - Dormant Projects
Streptococcus pyogenes Infections - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Streptococcus pyogenes Infections, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Streptococcus pyogenes Infections - Pipeline by Absynth Biologics Ltd, H2 2018
Streptococcus pyogenes Infections - Pipeline by AstraZeneca Plc, H2 2018
Streptococcus pyogenes Infections - Pipeline by Cadila Pharmaceuticals Ltd, H2 2018
Streptococcus pyogenes Infections - Pipeline by Crestone Inc, H2 2018
Streptococcus pyogenes Infections - Pipeline by Helix BioMedix Inc, H2 2018
Streptococcus pyogenes Infections - Pipeline by Wellstat Vaccines LLC, H2 2018
Streptococcus pyogenes Infections - Dormant Projects, H2 2018
Streptococcus pyogenes Infections - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Streptococcus pyogenes Infections, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018
  • Global (United States, European Union and China) Tigecycline Market Research Report 2019-2025
    Published: 22-Apr-2019        Price: US 3280 Onwards        Pages: 127
    In 2019, the market size of Tigecycline is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tigecycline. This report studies the global market size of Tigecycline, e......
  • Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025
    Published: 19-Apr-2019        Price: US 3900 Onwards        Pages: 114
    The global Meningococcal Infections Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Meningococcal Infections Vaccine market based on company, product type, end user and key regions. This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, ......
  • Global Famciclovir Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 17-Apr-2019        Price: US 3100 Onwards        Pages: 146
    The Famciclovir market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Famciclovir. Global Famciclovir industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, growth rate), gross......
  • Global (United States, European Union and China) Miconazole Nitrate Market Research Report 2019-2025
    Published: 17-Apr-2019        Price: US 3280 Onwards        Pages: 114
    In 2019, the market size of Miconazole Nitrate is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Miconazole Nitrate. This report studies the global market size of ......
  • Global Voriconazole Market Insights, Forecast to 2025
    Published: 16-Apr-2019        Price: US 3900 Onwards        Pages: 128
    The global Voriconazole market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Voriconazole market based on company, product type, end user and key regions. This report studies the global market size of Voriconazole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on......
  • Global Aspergillosis Drugs Market Analysis 2013-2018 and Forecast 2019-2024
    Published: 13-Apr-2019        Price: US 2980 Onwards        Pages: 80
    Summary The global Aspergillosis Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Aspergillosis Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this repor......
  • Global Aspergillosis Drugs Market Research Report 2019
    Published: 12-Apr-2019        Price: US 2900 Onwards        Pages: 104
    The global Aspergillosis Drugs market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Aspergillosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aspergillosis Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, ......
  • Global Drugs For Herpes Labialis (Oral Herpes) Market Data Survey Report 2013-2025
    Published: 12-Apr-2019        Price: US 1500 Onwards        Pages: 76
    Summary Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2-3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original......
  • Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Research Report 2019
    Published: 11-Apr-2019        Price: US 2900 Onwards        Pages: 97
    The global Drugs for Vancomycin-Resistant Enterococcus Faecium market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Drugs for Vancomycin-Resistant Enterococcus Faecium volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Vancomycin-Resistant Enterococcus Faecium market size by analyzing historical d......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs